Clinical Trials Directory

Trials / Completed

CompletedNCT02307253

EUS GUIDED Transduodenal Biopsy Using the 19G Flex

EUS-guided Fine Needle Tissue Acquisition Using a Newly Developed Nitinol Ultra Flex 19 Gauge Needle for Transduodenal Lesions: a Multicenter Prospective Feasibility Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
246 (actual)
Sponsor
Catholic University of the Sacred Heart · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

This study evaluates the feasibility, safety and accuracy of a 19 gauge (19G) needle in nitinol in the performance of endoscopic ultrasound (EUS) guided transduodenal biopsy for the acquisition of samples for histologic analysis. Patients with lesions that can be approached only from the duodenum will be prospectively enrolled.

Detailed description

A 19 gauge needle in nitinol (Flex needle) has been recently become available for EUS guided procedure. The use of nitinol should guarantee a better needle flexibility with a theoretical advantage on the use of this needle for lesions that need to be sampled through the duodenum. Moreover, samples for histologic examination seems to be easy to interpret than cytologic ones allowing evaluate of the overall architecture of the tissue, better performance of immunohistochemical staining, and may be of additional value to perform tissue profiling that in the future will be very important to guide individualized therapies The existing data on the performance of the Flex needle for EUS-guided transduodenal biopsy are coming form a single study performed in one single center. Thus, the reproducibility of these results is unknown and multicenter prospective studies are warranted to answer this important question.

Conditions

Interventions

TypeNameDescription
DEVICEExpect™19Flex needle (Boston Scientific Corp.,Natick,MA,USA)EUS-guided fine needle biopsy performed through the duodenum with the Expect™ 19 Flex needle

Timeline

Start date
2013-06-01
Primary completion
2015-10-01
Completion
2015-10-01
First posted
2014-12-04
Last updated
2022-06-27
Results posted
2022-06-27

Locations

6 sites across 4 countries: United States, France, Italy, Japan

Source: ClinicalTrials.gov record NCT02307253. Inclusion in this directory is not an endorsement.